ArticleCancer cell international2021

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.

Qiuxian Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.